Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions β€” written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Hemochromatosis differential diagnosis

Introduction

Overview

Overview

Haemochromatosis should be differentiate from other disorders with iron overload. Iron overload can be sue to iron absorption, or iron overload. Diseases in this category are: hemochromatosis, Thalassemia, chronic liver disease, sideroblastic anemia, african iron overload, and transfusion iron overload.

Differentiating Hemochromatosis from other Diseases

Differentiating Hemochromatosis from other Diseases

Haemochromatosis should be differentiate from other disorders with iron overload. Iron overload can be sue to iron absorption, or iron overload. Diseases in this category are: hemochromatosis, Thalassemia, chronic liver disease, sideroblastic anemia, african iron overload, and transfusion iron overload.

Different causes of iron overload
Category Disorder Etiology Laboratory abnormalities Physical examination Mechanism
Increased Iron absorption Hemochromatosis[1][2][3][4][5]
Thalassemia[6]
Chronic liver disease[8][9][10][11]
  • Impaired liver function tests with hepatocellular pattern
  • High ferritin
Sideroblastic anemia[12][13][14]
African iron overload[15][16] Insert paragraph Increase iron absorption from intestine
Increased Iron intake Transfusional overload
  • Recurrent blood transfusion for any reason
Hemin infusion
References

References

  1. ↑ Hemochromatosis-Diagnosis National Digestive Diseases Information Clearinghouse, National Institutes of Health, U.S. Department of Health and Human Services
  2. ↑ Crownover BK, Covey CJ (2013). “Hereditary hemochromatosis”. Am Fam Physician. 87 (3): 183–90. PMIDΒ 23418762.
  3. ↑ Nielsen J, Jensen L, Krabbe K (1995). “Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome”. J Neurol Neurosurg Psychiatry. 59 (3): 318–21. PMIDΒ 7673967.
  4. ↑ Costello D, Walsh S, Harrington H, Walsh C (2004). “Concurrent hereditary haemochromatosis and idiopathic Parkinson’s disease: a case report series”. J Neurol Neurosurg Psychiatry. 75 (4): 631–3. PMIDΒ 15026513.
  5. ↑ Salgia RJ, Brown K (2015). “Diagnosis and management of hereditary hemochromatosis”. Clin Liver Dis. 19 (1): 187–98. doi:10.1016/j.cld.2014.09.011. PMIDΒ 25454304.
  6. ↑ Gibbons RJ (2012). “Ξ±-Thalassemia, mental retardation, and myelodysplastic syndrome”. Cold Spring Harb Perspect Med. 2 (10). doi:10.1101/cshperspect.a011759. PMCΒ 3475406. PMIDΒ 23028133.
  7. ↑ Chui DH, Cunningham MJ, Luo HY, Wolfe LC, Neufeld EJ, Steinberg MH (2006). “Screening and counseling for thalassemia”. Blood. 107 (4): 1735–7. doi:10.1182/blood-2005-09-3557. PMCΒ 1895412. PMIDΒ 16461765.
  8. ↑ Ceni E, Mello T, Galli A (2014). “Pathogenesis of alcoholic liver disease: role of oxidative metabolism”. World J. Gastroenterol. 20 (47): 17756–72. doi:10.3748/wjg.v20.i47.17756. PMCΒ 4273126. PMIDΒ 25548474.
  9. ↑ Mathurin P, Bataller R (2015). “Trends in the management and burden of alcoholic liver disease”. J. Hepatol. 62 (1 Suppl): S38–46. doi:10.1016/j.jhep.2015.03.006. PMCΒ 5013530. PMIDΒ 25920088.
  10. ↑ Lucey MR, Mathurin P, Morgan TR (2009). “Alcoholic hepatitis”. N. Engl. J. Med. 360 (26): 2758–69. doi:10.1056/NEJMra0805786. PMIDΒ 19553649.
  11. ↑ Datz C, MΓΌller E, Aigner E (June 2017). “Iron overload and non-alcoholic fatty liver disease”. Minerva Endocrinol. 42 (2): 173–183. doi:10.23736/S0391-1977.16.02565-7. PMIDΒ 27834478.
  12. ↑ Cazzola M, Invernizzi R (June 2011). “Ring sideroblasts and sideroblastic anemias”. Haematologica. 96 (6): 789–92. doi:10.3324/haematol.2011.044628. PMCΒ 3105636. PMIDΒ 21632840.
  13. ↑ Bottomley SS, Fleming MD (August 2014). “Sideroblastic anemia: diagnosis and management”. Hematol. Oncol. Clin. North Am. 28 (4): 653–70, v. doi:10.1016/j.hoc.2014.04.008. PMIDΒ 25064706.
  14. ↑ Long Z, Li H, Du Y, Han B (August 2018). “Congenital sideroblastic anemia: Advances in gene mutations and pathophysiology”. Gene. 668: 182–189. doi:10.1016/j.gene.2018.05.074. PMIDΒ 29787825.
  15. ↑ Gordeuk VR (October 2002). “African iron overload”. Semin. Hematol. 39 (4): 263–9. PMIDΒ 12382201.
  16. ↑ Gordeuk V, Caleffi A, Corradini E, Ferrara F, Jones R, Castro O, Onyekwere O, Kittles R, Pignatti E, Montosi G, Garuti C, Gangaidzo I, Gomo Z, Moyo V, Rouault T, MacPhail P, Pietrangelo A (2003). “Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene”. Blood Cells Mol Dis. 31 (3): 299–304. PMIDΒ 14636642.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]